|Title:||Administration of Schedule 8 medicines to patients attending for emergencies|
|Document ID:||Operational Directive OD 0142/08|
|Date of issue:||Tuesday, 29 July 2008|
|Description:||Policy on administration of Schedule 8 medicine in Emergency Departments.|
|Applicable to:||Hospital personnel|
|Framework:||Public Health Policy Framework|
|Period of effect:||from 9 July 2008 to 9 July 2013|
|Review date:||1 May 2013|
|Authorised by:||Dr Robyn Lawrence, A/DIRECTOR GENERAL, WA HEALTH, 18-Jul-2008|
|Print version:||View print version|
Administration of Schedule 8 medicines to patients attending for emergencies
Patients who attend hospital Emergency Departments (ED) may require treatment with Schedule 8 medicines.
There are cases on record where the patient has presented to the ED with the primary intent of seeking access to Schedule 8 medicines. Some of these patients have subsequently been found to be notified drug addicts. Treating a drug addict with a Schedule 8 medicine is contrary to the Poisons Regulations 1965 unless specific prior authorisation has been given.
In order to minimise the risk of inappropriate treatment with Schedule 8 medicines, all patients for whom the administration of a Schedule 8 medicine is being considered must be:
Historically, some patients have accessed Schedule 8 medicines from hospital emergency departments as part of their ongoing treatment of chronic conditions (which may be associated with acute episodes). This has primarily occurred in areas where a medical practitioner is not immediately available at the hospital.
In hospitals without on-site medical staff and where a medical practitioner, practising at the hospital, has decided that a patient is to receive an ongoing prescription for a Schedule 8 medicine within the ED, then this must have prior approval of the relevant Director of Clinical Services (DCS) or Regional Medical Director. An application detailing the justification of ongoing treatment, diagnosis, drug and dose of each patient’s treatment must be made to the relevant DCS and this approval is to be reviewed every 12 months.
Dr Robyn Lawrence
This circular last updated: Tuesday, 29 July 2008 at 1:53pm